Testing effectiveness (Phase 2)Study completedNCT00055237
What this trial is testing
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Who this might be right for
Kaposi's SarcomaHIV InfectionsHIV Seronegativity
National Cancer Institute (NCI) 19